NCT01848223

Brief Summary

The purpose of this study is to evaluate the quality of life of late postmenopausal Finnish women and the factors affecting it.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 2, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 7, 2013

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

May 7, 2013

Status Verified

May 1, 2013

Enrollment Period

1.5 years

First QC Date

May 2, 2013

Last Update Submit

May 2, 2013

Conditions

Quality of Life

Keywords

quality of lifeQoLlate menopause

Outcome Measures

Primary Outcomes (1)

  • quality of life

    seventeen years

Study Arms (1)

late menopause

Eligibility Criteria

Age64 Years - 82 Years
Sexfemale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

community sample of the area of Turku

You may qualify if:

  • a previous hysterectomy for benign reason
  • postmenopausal status (serum follicle stimulating hormone (FSH) level over 26 U/l)

You may not qualify if:

  • a history of previous head injury
  • a chronic somatic or mental disease
  • abuse of alcohol or medicines
  • smoking (over 10 cigarettes daily)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Turku and Turku University Hospital

Turku, 20100, Finland

RECRUITING

Study Officials

  • Riina Katainen, MD

    University of Turku and Turku University Hospital

    PRINCIPAL INVESTIGATOR

  • Päivi Polo, MD,PhD

    University of Turku and Turku University Hospital

    STUDY DIRECTOR

Central Study Contacts

Riina Katainen

CONTACT

+35823130000riina.katainen@utu.fi

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2013

First Posted

May 7, 2013

Study Start

November 1, 2012

Primary Completion

May 1, 2014

Study Completion

December 1, 2016

Last Updated

May 7, 2013

Record last verified: 2013-05

Locations

FI(1)